291 related articles for article (PubMed ID: 26911397)
41. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
42. Adjunctive psychosocial therapies for the treatment of schizophrenia.
Patterson TL; Leeuwenkamp OR
Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500
[TBL] [Abstract][Full Text] [Related]
43. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
44. Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.
Rosenheck RA; Krystal JH; Lew R; Barnett PG; Thwin SS; Fiore L; Valley D; Huang GD; Neal C; Vertrees JE; Liang MH;
Clin Trials; 2011 Apr; 8(2):196-204. PubMed ID: 21270143
[TBL] [Abstract][Full Text] [Related]
45. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia.
Montes JM; Medina E; Gomez-Beneyto M; Maurino J
Psychiatry Res; 2012 Dec; 200(2-3):89-95. PubMed ID: 22901437
[TBL] [Abstract][Full Text] [Related]
46. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence.
Pakpour AH; Gholami M; Esmaeili R; Naghibi SA; Updegraff JA; Molloy GJ; Dombrowski SU
Epilepsy Behav; 2015 Nov; 52(Pt A):133-42. PubMed ID: 26414343
[TBL] [Abstract][Full Text] [Related]
47. Attitudes to Medication-Treatment Among Patients and Caregivers: A Longitudinal Comparison of Bipolar Disorder and Schizophrenia From India.
Chauhan N; Chakrabarti S; Grover S
J Clin Psychopharmacol; 2020; 40(1):18-29. PubMed ID: 31804452
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
[TBL] [Abstract][Full Text] [Related]
49. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia.
Granholm E; McQuaid JR; McClure FS; Auslander LA; Perivoliotis D; Pedrelli P; Patterson T; Jeste DV
Am J Psychiatry; 2005 Mar; 162(3):520-9. PubMed ID: 15741469
[TBL] [Abstract][Full Text] [Related]
50. [The long-term treatment of schizophrenia].
Herold R
Orv Hetil; 2012 Jul; 153(26):1007-12. PubMed ID: 22735371
[TBL] [Abstract][Full Text] [Related]
51. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
52. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
[TBL] [Abstract][Full Text] [Related]
53. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
[TBL] [Abstract][Full Text] [Related]
54. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
55. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
56. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
Chang YT; Tao SG; Lu CL
Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
[TBL] [Abstract][Full Text] [Related]
57. Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia.
Lam JW; Lui SS; Wang Y; Chan RC; Cheung EF
Schizophr Res; 2013 Jul; 147(2-3):293-300. PubMed ID: 23631929
[TBL] [Abstract][Full Text] [Related]
58. The effect of motivational interviews on treatment adherence and insight levels of patients with schizophrenia: A randomized controlled study.
Ertem MY; Duman ZÇ
Perspect Psychiatr Care; 2019 Jan; 55(1):75-86. PubMed ID: 29888541
[TBL] [Abstract][Full Text] [Related]
59. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
60. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]